Skip to main content
. Author manuscript; available in PMC: 2019 Jan 3.
Published in final edited form as: Ann Intern Med. 2018 May 29;169(1):1–9. doi: 10.7326/M17-2561

Figure 2.

Figure 2

Figure 2

Figure 2

Panel A. For each quintile of competing mortality risk, quality adjusted life year (QALY) gains (y-axis) by baseline lung cancer risk (x-axis) under base-case assumptions. Baseline lung cancer risk is by percentile from 0–100. Incremental QALY gains from LDCT screening decline as competing mortality risk increases.

Panel B. Quality adjusted life year (QALY) gains for highest (5th) quintile of competing mortality risk, by baseline lung cancer risk (x-axis).

Panel C. Quality adjusted life year (QALY) gains when excluding persons in highest (5th) quintile of competing mortality risk, by baseline lung cancer risk (x-axis).